UT research on treatment of triple-negative breast cancer receives $1.4 million funding award

January 26, 2021 | UToledo in the News, Pharmacy and Pharmaceutical Sciences
By Christine Billau



Researchers at The University of Toledo have received a three-year funding award of $1.4 million from the U.S. Department of Defense for a pre-clinical study of promising new chemotherapy aimed at triple negative breast cancer.

Read: UT research on treatment of triple-negative breast cancer receives $1.4 million funding award